As filed with the Securities and Exchange Commission on January 31, 2014
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
OPHTHOTECH CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Delaware |
|
20-8185347 |
(State or Other Jurisdiction of Incorporation or Organization) |
|
(I.R.S. Employer |
|
|
|
One Penn Plaza, 35th Floor |
|
10119 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
2013 Stock Incentive Plan
(Full Title of the Plan)
David R. Guyer, M.D.
Chief Executive Officer
Ophthotech Corporation
One Penn Plaza, 35th Floor
New York, New York 10119
(Name and Address of Agent for Service)
(212) 845-8200
(Telephone Number, Including Area Code, of Agent For Service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b of the Exchange Act.
Large accelerated filer o |
|
Accelerated filer o |
|
|
|
Non-accelerated filer x |
|
Smaller reporting company o |
(Do not check if a smaller reporting company) |
|
|
CALCULATION OF REGISTRATION FEE
Title of |
|
Amount to be |
|
Proposed |
|
Proposed |
|
Amount of |
| |||
Common Stock, $0.001 par value per share |
|
1,256,528 shares |
|
$ |
30.36 |
(2) |
$ |
38,149,115 |
(2) |
$ |
4,914.00 |
|
(1) In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.
(2) Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(h) of the Securities Act of 1933, as amended. The price per share and aggregate offering price are calculated on the basis of (a) $31.29, the weighted average exercise price of 422,495 shares subject to outstanding stock option grants under the 2013 Stock Incentive Plan that have not previously been registered under the Securities Act of 1933, as amended, and (b) $29.89, the average of the high and low sale prices of the Registrants Common Stock as reported on The NASDAQ Global Select Market on January 27, 2014, in accordance with Rule 457(c) under the Securities Act of 1933, as amended, for the remaining 834,033 shares issuable under the 2013 Stock Incentive Plan which are not yet subject to outstanding options.
EXPLANATORY NOTE
This Registration Statement on Form S-8, relating to the 2013 Stock Incentive Plan of Ophthotech Corporation (the Registrant), is being filed for the purpose of registering additional securities of the same class as other securities for which a Registration Statement on Form S-8 has previously been filed and is effective. Accordingly, this Registration Statement incorporates by reference the contents of the Registration Statement on Form S-8, File No. 333-191767, filed with the Securities and Exchange Commission on October 16, 2013 by the Registrant, relating to the Registrants Amended and Restated 2007 Stock Incentive Plan, as amended, and 2013 Stock Incentive Plan, except for Item 8, Exhibits, with respect to which the Exhibit Index immediately preceding the exhibits attached hereto is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on this 31st day of January, 2014.
|
OPHTHOTECH CORPORATION | |
|
By: |
/s/ David R. Guyer |
|
|
David R. Guyer, M.D. |
|
|
Chief Executive Officer |
POWER OF ATTORNEY AND SIGNATURES
We, the undersigned officers and directors of Ophthotech Corporation, hereby severally constitute and appoint David R. Guyer, Samir C. Patel and Bruce Peacock, and each of them singly, our true and lawful attorneys with full power to them, and each of them singly, to sign for us and in our names in the capacities indicated below, the Registration Statement on Form S-8 filed herewith and any and all subsequent amendments to said Registration Statement, and generally to do all such things in our names and on our behalf in our capacities as officers and directors to enable Ophthotech Corporation to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorneys, or any of them, to said Registration Statement and any and all amendments thereto.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/ David R. Guyer |
|
Chief Executive Officer and Chairman of the Board of Directors (principal executive officer) |
|
January 31, 2014 |
David R. Guyer, M.D. |
|
|
|
|
/s/ Samir C. Patel |
|
President and Vice Chairman of the Board of Directors |
|
January 31, 2014 |
Samir C. Patel, M.D. |
|
|
|
|
/s/ Bruce Peacock |
|
Chief Financial and Business Officer (principal financial officer) |
|
January 31, 2014 |
Bruce Peacock |
|
|
|
|
|
|
|
|
|
/s/ Axel Bolte |
|
Director |
|
January 31, 2014 |
Axel Bolte |
|
|
|
|
|
|
|
|
|
/s/ Thomas Dyrberg |
|
Director |
|
January 31, 2014 |
Thomas Dyrberg, M.D., D.M.Sc. |
|
|
|
|
|
|
|
|
|
/s/ Nicholas Galakatos |
|
Director |
|
January 31, 2014 |
Nicholas Galakatos, Ph.D. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Michael Ross |
|
Director |
|
January 31, 2014 |
Michael Ross, Ph.D. |
|
|
|
|
|
|
|
|
|
/s/ Glenn Sblendorio |
|
Director |
|
January 31, 2014 |
Glenn Sblendorio |
|
|
|
|
INDEX TO EXHIBITS
Number |
|
Description |
|
|
|
4.1* |
|
Restated Certificate of Incorporation of the Registrant |
|
|
|
4.2* |
|
Amended and Restated By-Laws of the Registrant |
|
|
|
5.1 |
|
Opinion of Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Registrant |
|
|
|
23.1 |
|
Consent of Wilmer Cutler Pickering Hale and Dorr LLP (included in Exhibit 5.1) |
|
|
|
23.2 |
|
Consent of Ernst &Young LLP |
|
|
|
24.1 |
|
Power of attorney (included on the signature pages of this registration statement) |
|
|
|
99.1* |
|
2013 Stock Incentive Plan |
* Previously filed with the Securities and Exchange Commission as an Exhibit to the Registrants Registration Statement on Form S-1, as amended (File No. 333-190643) and incorporated herein by reference.
Exhibit 5.1
+1 212 230 8800 (t)
+1 212 230 8888 (f)
wilmerhale.com
January 31, 2014
Ophthotech Corporation
One Penn Plaza, 35th Floor
New York, NY 10119
Re: Ophthotech Corporation
Registration Statement on Form S-8
2013 Stock Incentive Plan
Ladies and Gentlemen:
We have assisted in the preparation of a Registration Statement on Form S-8 (the Registration Statement) to be filed with the Securities and Exchange Commission (the Commission) under the Securities Act of 1933, as amended (the Securities Act), relating to an aggregate of 1,256,528 shares of common stock, $0.001 par value per share (the Shares), of Ophthotech Corporation, a Delaware corporation (the Company), issuable under the Companys 2013 Stock Incentive Plan (the Plan).
We have examined the Certificate of Incorporation and Bylaws of the Company, each as amended and/or restated to date, and originals, or copies certified to our satisfaction, of all pertinent records of the meetings of the directors and stockholders of the Company, the Registration Statement and such other documents relating to the Company as we have deemed material for the purposes of this opinion.
In our examination of the foregoing documents, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, photostatic or other copies, the authenticity of the originals of any such documents and the legal competence of all signatories to such documents.
We assume that the appropriate action will be taken, prior to the offer and sale of the Shares in accordance with the Plan, to register and qualify the Shares for sale under all applicable state securities or blue sky laws.
We express no opinion herein as to the laws of any state or jurisdiction other than the state laws of the State of New York, the General Corporation Law of the State of Delaware and the federal laws of the United States of America.
It is understood that this opinion is to be used only in connection with the offer and sale of the Shares while the Registration Statement is in effect.
Please note that we are opining only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters.
Based on the foregoing, we are of the opinion that the Shares have been duly authorized for issuance and, when the Shares are issued and paid for in accordance with the terms and conditions of the Plan, the Shares will be validly issued, fully paid and nonassessable.
We hereby consent to the filing of this opinion with the Commission in connection with the Registration Statement in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act. In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission.
Very truly yours,
WILMER CUTLER PICKERING
HALE AND DORR LLP
By: |
/s/ Brian A. Johnson |
|
|
Brian A. Johnson, a Partner |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2013 Stock Incentive Plan, of Ophthotech Corporation of our report dated July 11, 2013 (except as to the thirteenth paragraph of Note 16 as to which the date is September 9, 2013), with respect to the financial statements of Ophthotech Corporation for the year ended December 31, 2012 included in the Registration Statement (Form S-1 No. 333-190643) and the related Prospectus, filed with the Securities and Exchange Commission.
|
/s/ Ernst & Young LLP |
MetroPark, New Jersey | |
January 30, 2014 |